NEWS AND MEDIA

News Releases

Patient Groups Object to Proposals to Increase Cost Sharing for Drugs

Proposals to Favor Generics Appear Sensible, but All Will Impede Access to Critical Medications Washington, DC – Today, the I Am Essential coalition submitted comments, signed by 87 patient and consumer groups, to the Department of Health and Human Services (HHS) urging them to reject proposals that would increase patient cost-sharing as they access life-changing…

Read more

Sign on to I Am Essential Draft Comments for 2020 Notice of Benefit and Payment Parameters

The “I Am Essential” coalition has prepared draft comments for organizational sign-on in response to the Administration’s 2020 Notice of Benefit and Payment Parameters (NBPP). The NBPP includes a wide range of proposed changes to qualified health plans that would, if finalized, add costs and reduce access to care for beneficiaries. Our comments focus on the proposals that could jeopardize broad…

Read more

102 Patient Groups Urge HHS to Reduce Patient Cost-Sharing for Prescription Drugs

Today, the I Am Essential coalition submitted comments, signed by 102 patient groups, to the U.S. Department of Health and Human Services in response to the President’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. The  comments focus on proposals contained in the Request for Information (RFI) that address efforts to reduce patient cost-sharing for prescription drugs in qualified health plans. In…

Read more

Sign-on to Support Proposals to Lower Patient Out-of-Pocket Costs

The “I Am Essential” coalition has prepared draft comments for organizational sign-on in response to the President’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Our comments focus on proposals contained in the Request for Information (RFI) that address efforts to reduce patient cost-sharing in qualified health plans. The letter outlines proposals the Administration could take to…

Read more

Media Contact

Carl Schmid

(202) 669-8267

For Media Inquiries, please contact Carl Schmid of The AIDS Institute.

EMAIL CARL